Investigating the role of vitamin B6 in treating acute myeloid leukemia
Characterizing vitamin B6 pathway dependency in acute myeloid leukemia
This study is looking at how vitamin B6 helps the growth of acute myeloid leukemia (AML) cells, with the hope of finding new ways to treat this fast-growing blood cancer and improve outcomes for patients.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cold Spring Harbor Laboratory NIH-funded |
| Lab location | 1 site (Cold Spring Harbor, United States) |
| Project ID | NIH-11002269 on NIH RePORTER |
What this research studies
This research focuses on acute myeloid leukemia (AML), a severe blood cancer that progresses rapidly and has limited treatment options. The study aims to explore how the vitamin B6 pathway is crucial for the growth of AML cells, potentially identifying new therapeutic targets. By understanding the metabolic dependencies of AML on vitamin B6, the researchers hope to develop more effective combination therapies that could improve patient outcomes. The approach involves examining key enzymes in the vitamin B6 metabolic pathway that are essential for AML cell proliferation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute myeloid leukemia, particularly those who have not responded well to standard chemotherapy.
Not a fit: Patients with other types of leukemia or those who do not have acute myeloid leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, more effective treatments for patients with acute myeloid leukemia.
How similar studies have performed: While the specific focus on the vitamin B6 pathway in AML is novel, similar metabolic targeting approaches have shown promise in other cancers.
Where this research is happening
Cold Spring Harbor, United States
- Cold Spring Harbor Laboratory — Cold Spring Harbor, United States (Active)
Researchers
- Principal investigator: Zhang, Lingbo — Cold Spring Harbor Laboratory
- Study coordinator: Zhang, Lingbo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.